Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-7325
Donath, M Y; Schumann, D M; Faulenbach, M; Ellingsgaard, H; Perren, A; Ehses, J A (2008). Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care, 31 Sup:S161-S164.
- Registered users only
View at publisher
Decreases in both mass and secretory function of insulin-producing beta-cells contribute to the pathophysiology of type 2 diabetes. The histology of islets from patients with type 2 diabetes displays an inflammatory process characterized by the presence of cytokines, apoptotic cells, immune cell infiltration, amyloid deposits, and eventually fibrosis. This inflammatory process is probably the combined consequence of dyslipidemia, hyperglycemia, and increased circulating adipokines. Therefore, modulation of intra-islet inflammatory mediators, in particular interleukin-1 beta, appears as a promising therapeutic approach.
3 downloads since deposited on 05 Jan 2009
0 downloads since 12 months
|Item Type:||Journal Article, refereed, further contribution|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Endocrinology and Diabetology|
|Dewey Decimal Classification:||610 Medicine & health|
|Deposited On:||05 Jan 2009 11:07|
|Last Modified:||27 Nov 2013 19:58|
|Publisher:||American Diabetes Association|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page